White Paper

The State of the Biopharma Contract Manufacturing Industry

White Paper

The State of the Biopharma Contract Manufacturing Industry

Assessing the Impact of COVID-19, Industry 4.0 and Flexible Design

With growing demands, rising costs, and increasingly complex technologies, CMOs are in a more strategic position to serve as skilled providers of the industry’s most advanced manufacturing processes, giving biopharma companies access to expertise and equipment often not feasible to procure internally.

The demand for biopharma contract manufacturing services is at an all-time high. So how did we get here, and where is the industry going?

Read the White Paper

Download this white paper to explore four factors influencing the growing CMO market and learn how to choose a CMO partner that’s right for you.